The opioid crisis continues to devastate families and communities across Canada. According to the Public Health Agency of Canada, an estimated 12,800 Canadians died from an apparent opioid-related overdose between January 2016 and March 2019. This is a complex issue that requires a compassionate, multi-faceted, evidence-based response. One of those facets is health economics, the branch of economics concerned with how to best allocate scarce health care resources for maximum benefit. In this lecture, the role and impact of health economics in supporting decision-making will be explored using the case study of the cost-effectiveness of naloxone kits in Canadian high schools and community centre settings.
0 Comments